• Info
  • Insider Ownership

Insider Trading & Ownership of Leslie Holsinger

Location
South San Francisco, CA
Summary
The estimated net worth of Leslie Holsinger is at least $139,195 dollars as of 08 Jun 2022. Leslie Holsinger is the EVP, Preclinical Development of Cortexyme, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $139.2K.
Signature
/s/ Caryn Gordon McDowell, as Attorney-in-Fact for Leslie Holsinger
All Insider Reports
All Insider Reports

Notify me when Leslie Holsinger files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Leslie Holsinger

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QNCX Quince Therapeutics, Inc. EVP, Preclinical Development $139,195 06 Jun 2022

Insider Transactions Reported by Leslie Holsinger:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.